Insider Transactions Reported by 14 Insiders of Cabaletta Bio, Inc.

Symbol
CABA on Nasdaq
Location
Philadelphia, PA

Insiders trading volume in the past year

Cabaletta Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
5AM Ventures V, L.P. 10%+ Owner $6,771,685 01 Nov 2021
Nichtberger Steven President & CEO, Director $3,104,976 +$100,778 +3.4% 21 Jan 2026
Mark Simon Director $351,516 +$25,261 +7.7% 21 Jan 2026
Gwendolyn Binder President, Science & Tech. $68,545 +$24,763 +57% 21 Jan 2026
Shawn Tomasello Director $50,322 +$50,322 21 Jan 2026
Steve Gavel Chief Commercial Officer $50,215 +$50,215 21 Jan 2026
David J. Chang Chief Medical Officer $19,887 +$19,888 21 Jan 2026
Michael Gerard General Counsel $14,979 +$14,979 21 Jan 2026
Catherine Bollard Director $12,248 +$9,982 +441% 21 Jan 2026
RICHARD C. HENRIQUES JR Director 09 Jun 2025
Anup Marda Chief Financial Officer 19 May 2025
Arun Das Chief Business Officer 19 May 2025
Scott C. Brun Director 09 Jun 2025
BRIAN DANIELS Director 01 Jun 2021

Recent Insider Transactions by Companies or Individuals for Cabaletta Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.